Calcitonin, Osteocalcin and Osteopontin in Lung Cancer

Autor: H.S. Taktashov, O.A. Homozova, O.V. Syniachenko, Yu.V. Dumanskyi, V.A. Stepko

Publikováno v: INTERNATIONAL JOURNAL OF ENDOCRINOLOGY; № 4.76 (2016); 26-30
Международный эндокринологический журнал-Mìžnarodnij endokrinologìčnij žurnal; № 4.76 (2016); 26-30
Міжнародний ендокринологічний журнал-Mìžnarodnij endokrinologìčnij žurnal; № 4.76 (2016); 26-30

ackground. Lung cancer markers are low levels of the hormone calcitonin in the blood, and high levels of proteins osteocalcin and osteopontin, connected to each other, reflect the processes of bone metastasis and have a predictive value. Objective: t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d303abefb7fbd1171401ad2a0a9ad5e
https://doi.org/10.22141/2224-0721.4.76.2016.77795

Calcitonin level in the postoperative period as a risk factor for persistence of medular thyroid cancer

Autor: O. A. Tovkai, V. O. Palamarchuk, V. A. Smolyar, V. V. Kuts, R. M. Sichinava

Publikováno v: Clinical Endocrinology and Endocrine Surgery; No. 4 (2021); 9-18
Clinical Endocrinology and Endocrine Surgery; № 4 (2021); 9-18

Aim — to evaluate the possibility of using basal calcitonin levels in the postoperative period to assess the effectiveness of surgical treatment of medullary thyroid cancer and the likelihood of its persistence (recurrence). Materials and methods.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::860bcee6db52f9db468712ea2400af33
https://doi.org/10.30978/cees-2021-4-9

Побудова прогностичної моделі оцінки ризику наявності метастазів медулярного раку щитоподібної залози із застосуванням бінарної логістичної регресії

Publikováno v: Clinical Endocrinology and Endocrine Surgery; No. 1 (2022); 7-16
Clinical Endocrinology and Endocrine Surgery; № 1 (2022); 7-16

Background. Medullary thyroid cancer is a topical disease that is often accompanied by metastases. The danger of this pathology requires timely and adequate surgery. Objective to assess the prognostic value and informativeness of some clinical indica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=scientific_p::933bf5b6fd339ba1b8faeb37c56a6f60
http://jcees.endocenter.kiev.ua/article/view/254415

Рівень кальцитоніну в післяопераційний період як чинник ризику персистенції медулярного раку щитоподібної залози

Publikováno v: Clinical Endocrinology and Endocrine Surgery; No. 4 (2021); 9-18
Clinical Endocrinology and Endocrine Surgery; № 4 (2021); 9-18

Aim — to evaluate the possibility of using basal calcitonin levels in the postoperative period to assess the effectiveness of surgical treatment of medullary thyroid cancer and the likelihood of its persistence (recurrence). Materials and methods.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=scientific_p::e9f05c921bf7722c1034158aeae18396
http://jcees.endocenter.kiev.ua/article/view/247227

Serum tumor markers in thyroid diseases

Autor: Makar, R.D., Vovk, V.I., Pavlovsky, I.M.

Publikováno v: INTERNATIONAL JOURNAL OF ENDOCRINOLOGY; Том 15, № 2 (2019); 158-164
Международный эндокринологический журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 15, № 2 (2019); 158-164
Міжнародний ендокринологічний журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 15, № 2 (2019); 158-164

The article highlights the role of serum tumor markers in the diagnosis and treatment of thyroid diseases, primarily various forms of cancer. Clinical indications for the prescription and current recommendations for evaluating the results of thyroglo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=scientific_p::61edd7926b1eecc6f43e5ff0c87ba7fb
http://iej.zaslavsky.com.ua/article/view/166110